home All News open_in_new Full Article

Zenas Bio inks potential $2 billion licensing deal with China's InnoCare for autoimmune drug

Zenas Bio inks potential $2 billion licensing deal with China's InnoCare for autoimmune drug  Reuters


today 1 week ago attach_file Economics

attach_file Politics
attach_file Society
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Events
attach_file Politics
attach_file Events
attach_file Events
attach_file Politics
attach_file Politics
attach_file Events
attach_file Events
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Events
attach_file Events


ID: 2206928764
Add Watch Country

arrow_drop_down